Prefilled Syringes Market Is Likely To Reach USD 22.5 Billion By 2025: Grand View Research, Inc.
The global prefilled syringes market size is expected to
reach USD 22.5 Billion by 2025, according to a new study by Grand View
Research, Inc. Key factors driving the market expansion include technological
advancements in auto-injectors and growing usage of prefilled syringes owing to
its reduced prices per dose.
Prefilled injecting devices are
rapidly replacing traditional syringe-vial combinations due to certain
associated advantages such as increased patient safety and convenience offered
to healthcare practitioners in dose preparation. Growing trend of
self-injecting devices adopted for the management of chronic diseases, such as
diabetes and rheumatoid arthritis, are expected to boost the growth of auto
injectors and pen injectors during the forecast period. Growing prevalence of
these diseases and introduction of advanced devices with Wi-Fi and Bluetooth
connectivity that facilitate effective management of patient health records are
factors expected to boost the usage of such devices.
Application of prefilled
injectors is currently limited to emergency rooms in hospitals and for the
treatment of certain chronic diseases. These injection devices are considered
ideal containers for vaccines and biotech drugs, which otherwise tend to become
unstable and react with the material of the container that result in altered
drug potency. Growing preference toward biotechnology drugs and the emerging
biotech space presenting greater opportunities are expected to have a positive
impact on the growth of the prefilled syringes market during the forecast
period.
Browse full research report on Prefilled Syringes Market: http://www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market
Further key findings from
the report suggest:
- The use of
glass syringes to be high owing to their increasing preference amongst
healthcare professionals; this is attributable to their ease of use and
the low risk posed by these devices at the time of injection.
- However, the
plastic segmentis rapidly replacing the former with the introduction of
advanced plastic materials, such as polypropylene and crystal clear
polymer, which are biocompatible as glass.
- Europe
dominated the prefilled syringes space in 2015. High adoption of patient
safety measures and presence of large number of market players are the
factors responsible for the dominance of the region.
- North America
region is expected to show the fastest growth rate during the forecast
period due to rapid adoption of prefilled syringes in this region.
- The market is
presently dominated by few key participants such as Gerresheimer AG,
Haselmeier AG, Nipro Medical Corporation, Unilife Corporation,Owen
Mumford, SCHOTT, Datwyler Pharma Packaging, and Becton, Dickinson and
Company.
- The syringe
manufacturing market is consolidated; however, various new players are
bringing innovative technologies to this sphere,which can be used for the
manufacturing of auto-injectors.
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-prefilled-syringes-market
About Grand View Research,
Inc:
Grand View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
For more information: http://www.grandviewresearch.com
Comments
Post a Comment